he Saudi Heart Association (SHA) and AstraZeneca signed a memorandum of understanding to strengthen cooperation in cardiovascular health. The agreement aims to translate scientific research and innovation into improvements in clinical practice and patient care in the Kingdom of Saudi Arabia.
The partnership will support cardiovascular research, scientific exchange through conferences and forums, and professional development for healthcare practitioners. It will also focus on improving hypertension care, cardiac care policies, clinical pathways, and the quality and efficiency of cardiovascular services in the Kingdom.
SHA President Prof. Waleed Al Habeeb said improving cardiovascular outcomes requires coordinated efforts across the healthcare system. He added that the partnership with AstraZeneca will strengthen research, develop healthcare professionals’ skills, and raise standards of cardiac care to help patients live longer, healthier lives.
Source: Riyadh Daily

